Index The entry for eta value (n-value) appears at the head of E. A Acid phosphatase production, and oxygen deficiency, 116 Acne, oxygen multistep therapy, 299-300 Age arteriovenous saturation differ ence r), 71-3 “biological age,” establishing and influencing, 36-7 and cardiac output, 69, 71-3 cardiopulmonal performance, 122 decline of physical reserves, 355 decrease in energy status, par ameters, 362 and “fitness apparatus”, 374 and mechanical performance re serve, 358 and 0 2 MT, 373 and oxygen multistep therapy im munostimulation, reduc tion of radiosensitivity of normal tissues, 350-2 oxygen multistep therapy in old age, 375 senile hypoxidosis, 324 Alupent see Orziprenalin Amputation, reversal of necrotic process with oxygen multistep therapy, 237 Anaerobic metabolism and capillary damage, 73 Angina effect of g-strophanthin, 86 and oxygen multistep therapy, lack of decompensation, 91 preinfarct stage, 288-9 Anticancer strategy, tumor im munology, 301-4 Anticancer therapy, and energy status, 364 Arterial wall “effective wall thickness,” par ameters, 295 endothelial injury, 295 increase in Po, ,, during O 2 MT, 15 lipid deposition, 112 nonspecific mesenchyme reac tion, 112 oxygen supply, 52, 296 Arterial wall Po2 increase, increase of inhaled oxygen, 264 Arterioles, parameters, 295 Arteriosclerosis application of oxygen multistep therapy, 266 pathological process, 264-5 prophylaxis, 263-4, 288 reversible/irreversible change, 265 Arteriovenous saturation differ ence n 24 h cycle, 19 as absolute characteristic value, 28-30 and age, 71—3 determination, 20-8 effect of stressful factors, 26 evaluation, 24 improvement with ginseng, 245 oxygen consumption, human organs, 94 see also m-valve Arthritis, oxygen multistep therapy, 299-300 ATP brain, rat model, 134-6 role in switching mechanism, 326 B BCG immunostimulation, 84 Bernouilli’s equation, 95 Berthold luminometer, 379 Be ssel’s equation, 95 Bicycle ergometer mechanical performance reserve, “energetic fate,” 356 specific exercise performance, 149-51 WHO criteria, 152 Biochemical energy requirements, and age, 359 “Biological age,” establishing and influencing, 36—7 Biological efficiency mechanical performance reserve, 356 MPR/MET, 356 Biomembranes, changes with pH reduction, 73-4 Birth see Childbirth Blood glucose level, correlation with pain, 120 Blood irradiation see Hemato ¬ genous oxygen therapy oxygen consumption, 94 sampling technique, POazart measurement, 200-1 viscosity, function of shear stress p s , various levels of hematocrit, 10 Blood pressure, increase in energy status, parameters, 362 Blood vessels dilatation, information store, 146-7 see also Arterial wall; Capil laries; Veins Blood-brain barrier, stabiliza tion, 117-9 Blood-nerve barrier electron micrograph, 119 and pain, 119-21 stabilization, 117-9 “Body contour effect”, 80 Bohr effect, 17 Brain see Cerebral cortex Broca’s index, and fasting, 298 cAMP, role in switching mech anism, 326 Cancer anticancer therapy, 301-4 cells killed, 367-8 indications for O 2 MT, 259 inoperable, before/after oxy gen multistep therapy, 307 metastasis formation, 308-13 prophylaxis in early stage, 305-7 see also Tumors Cancer (conventional) therapy, 307-8 with cancer multistep therapy immuno stimulation, 313-6 cancer multistep therapy re sults, 337-8 classical plus oxygen multi- step therapy, 303 and deterioration of oxygen status, 337 improvement using O 2 MT as adjunct, program, 339-40